Global Metabolomics Market Size (2024 - 2029)

The metabolomics market is projected to experience significant growth over the forecast period, driven by an increased awareness of its importance and applications, particularly in healthcare and drug discovery. The market's expansion is attributed to the rising demand for advanced analytical tools and solutions, which have been accelerated by the need for improved disease diagnosis and prognosis, especially in the context of infectious diseases like COVID-19. Despite initial setbacks due to the pandemic, the market is expected to recover and grow, supported by technological advancements and a growing focus on research and development.

Home Market Analysis Healthcare Research Biotechnology Research Biotechnology R&D Research Life Science Research Technologies Research Genomics Research Metabolomics Industry Market Size

Market Size of Global Metabolomics Industry

Global Metabolomics Market Industry Summary
Study Period 2019 - 2029
Market Size (2024) USD 2.26 Billion
Market Size (2029) USD 3.82 Billion
CAGR (2024 - 2029) 11.02 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Global Metabolomics Market Industry Major Players

*Disclaimer: Major Players sorted in no particular order

Metabolomics Market Analysis

The Global Metabolomics Market size is estimated at USD 2.26 billion in 2024, and is expected to reach USD 3.82 billion by 2029, growing at a CAGR of 11.02% during the forecast period (2024-2029).

The market was negatively impacted by the COVID-19 pandemic owing to the low availability of lab reagents, testing kits, and other analytics tools. However, the awareness of the importance of metabolomics among people improved after the pandemic started. To combat the COVID-19 infection, researchers actively started experiments to find more applications of metabolomics.

According to an article published in July 2021, titled 'Metabolomics in the Diagnosis and Prognosis of COVID-19', research on the application of metabolomics in the diagnosis of infectious diseases is accelerated, particularly in respiratory viral infection. This rising adoption rate of metabolomics as a research and development tool is anticipated to drive the metabolomics market. Metabolomics helps analyze diseases and biological processes better and has growing applications in healthcare and drug discovery.

The increasing prevalence of diseases in recent years resulted in a rise in the demand for metabolomics. This has driven the major players in the market to focus on technologically advanced solutions and analytical tools for the end-users. In June 2021, Bruker launched several products to enhance the accuracy of 4D metabolomics and lipidomics workflows, including a new ion source for its Trapped-ion Mobility Spectrometry Time-of-flight (timsTOF) Pro 2 platform. Also, in June 2021, Thermo Fischer Scientific launched the next generation of MS-Based Solutions Orbitrap IQ-X Tribrid mass spectrometer, which is specially designed for small-molecule structural elucidation of metabolites and unknown compounds.

Thus, owing to the above-mentioned factors, the metabolomics market is anticipated to grow over the forecast period.

Metabolomics Industry Segmentation

As per the scope of the report, metabolomics represents a systematic study of unique cellular chemical processes involving metabolites. The collection of all the metabolites in a biological cell, tissue, organ, or organism is called metabolome, which are the end products of cellular processes. In the past decade, scientific communities across the world have been integrating proteomic, transcriptomic, and metabolomic information, which helps in the early analysis of chronic genetic or infectious diseases. These are funded by several private and public entities, which helps in the growth of the metabolomics market.

The metabolomics market is segmented by metabolite analysis (analytical techniques, detection techniques, and bioinformatics tools and databases), application (biomarker and drug discovery, toxicology, nutrigenomics, personalized medicine, and other applications), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report also covers the market in 17 different countries and major regions worldwide. The report offers the market sizes and estimates in terms of value (in USD million) for the above segments.

By Metabolite Analysis
Analytical Techniques
Separation Techniques
Liquid Chromatography
Gas Chromatography
Capillary Electrophoresis
Detection Techniques
Mass Spectrometry
Nuclear Magnetic Resonance Spectroscopy
Other Detection Techniques
Bioinformatics Tools and Databases
By Application
Biomarker and Drug Discovery
Toxicology
Nutrigenomics
Personalized Medicine
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Metabolomics Market Size Summary

The metabolomics market is poised for significant growth, driven by its expanding applications in healthcare and drug discovery. The market's trajectory was initially hindered by the COVID-19 pandemic, which disrupted the availability of essential lab reagents and analytics tools. However, the pandemic also heightened awareness of metabolomics' potential, particularly in diagnosing infectious diseases. This increased awareness has spurred research and development, leading to a surge in demand for advanced metabolomics solutions. Major industry players are focusing on innovative technologies to meet this demand, with new product launches and strategic acquisitions enhancing their offerings. The biomarkers and drug discovery segment is expected to be a key contributor to market growth, as metabolomics plays a crucial role in identifying potential biomarkers for disease treatment and early diagnosis.

North America is anticipated to lead the metabolomics market during the forecast period, supported by a robust presence of major industry players and a high incidence of chronic diseases. The region benefits from substantial healthcare expenditure and well-established sales channels, which facilitate the adoption of metabolomics applications. Initiatives by organizations like the National Institute of Health further bolster the market by supporting research communities. The prevalence of chronic diseases in the United States drives the demand for advanced therapies and drug discovery, thereby increasing the application of metabolomics. The competitive landscape is characterized by collaborations among major companies and research institutions, fostering innovation and technical advancements. These factors collectively contribute to the expected healthy growth of the metabolomics market in North America.

Explore More

Global Metabolomics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Demand for Personalized Medicines

      2. 1.2.2 High Investments by Public and Private Sectors in Metabolomics

      3. 1.2.3 Rising Need for Early and Accurate Diagnosis of Diseases

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Tools and Instruments

      2. 1.3.2 Lack of Skilled Professionals

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value, USD million)

    1. 2.1 By Metabolite Analysis

      1. 2.1.1 Analytical Techniques

        1. 2.1.1.1 Separation Techniques

          1. 2.1.1.1.1 Liquid Chromatography

          2. 2.1.1.1.2 Gas Chromatography

          3. 2.1.1.1.3 Capillary Electrophoresis

        2. 2.1.1.2 Detection Techniques

          1. 2.1.1.2.1 Mass Spectrometry

          2. 2.1.1.2.2 Nuclear Magnetic Resonance Spectroscopy

          3. 2.1.1.2.3 Other Detection Techniques

      2. 2.1.2 Bioinformatics Tools and Databases

    2. 2.2 By Application

      1. 2.2.1 Biomarker and Drug Discovery

      2. 2.2.2 Toxicology

      3. 2.2.3 Nutrigenomics

      4. 2.2.4 Personalized Medicine

      5. 2.2.5 Other Applications

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Metabolomics Market Size FAQs

The Global Metabolomics Market size is expected to reach USD 2.26 billion in 2024 and grow at a CAGR of 11.02% to reach USD 3.82 billion by 2029.

In 2024, the Global Metabolomics Market size is expected to reach USD 2.26 billion.

Metabolomics Market Report Snapshots

Metabolomics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)